Recently another MITE-like structure, called the integron mobilization unit (IMU), has been described flanking a defective class 1 integron harbouring a carbapenem resistance gene, bla , in a clinical Enterobacter cloacae strain. Although the IMU sequence is not related to the MITE reported in our study, IMU-based mobilization of the integron could be demonstrated using a transposase provided in trans.
5 Similar mobilization has been described for MITEs. 3, 4 There are no data in the scientific literature on the prevalence of MITEs in clinical bacteria. This is the second report of this 439 bp MITE-like structure, but the first in a clinical strain of the emergent pathogenic species A. baumannii. Moreover, it is a unique structure surrounding an IMP-type carbapenemase, suggesting that this resistance-encoding integron can be mobilized by a transposition-like mechanism. Our study emphasizes the need to determine the genetic context of mobile elements to fully understand the history of and future potential for dissemination of resistance genes. Figure 1 . Schematic representation of the flanking regions of (a) the integron In76 of A. baumannii 65FFC (this study) and (b) the integron of A. johnsonii. 3 The regions between the dashed lines are 100% identical (1720/1720 bp and 3728/3728 bp).
Sir, Acinetobacter baumannii is an emerging Gram-negative multidrug-resistant (MDR) nosocomial pathogen responsible for causing lung, bloodstream, urinary tract and skin infections. Additionally, A. baumannii has emerged as a significant threat in injured US military personnel returning for medical treatment from Afghanistan and Iraq. 1 Because an increasing number of A. baumannii isolates are resistant to the most commonly clinically utilized antibiotics, it is imperative to understand the development of antibiotic resistance in A. baumannii at the molecular level. 2 Fluoroquinolones are broad-spectrum bactericidal agents used to treat diverse bacterial infections. Fluoroquinolones are emerging as viable alternatives for treating A. baumannii infections, but the clinical incidence of fluoroquinolone resistance continues to increase.
1,2 The most extensively described mechanism of resistance to fluoroquinolones is mediated by mutations in the quinolone resistance-determining regions (QRDRs) of gyrA that encodes the DNA gyrase A subunit and parC that encodes the topoisomerase IV subunit. 3 Additionally, resistance can also be mediated by efflux pumps such as AdeABC and AdeM. 3 Recently, plasmid-mediated quinolone resistance (PMQR) genes have been reported in Gram-negative bacteria, including Escherichia coli and Pseudomonas spp., and include the qnr, qep and oqx systems. The qnr system encodes a pentapeptide repeat protein that blocks the action of ciprofloxacin on bacterial DNA gyrase and topoisomerase IV and was first described in Klebsiella pneumoniae. In contrast, the qep and oqx systems encode plasmid-mediated efflux pumps. However, the PMQR genes have not been demonstrated in A. baumannii.
3
The prevalent theory is that the fluoroquinolone resistance is chiefly mediated by chromosomal mutation, whereas the acquisition of the PMQR genes results in enhancement of the resistance because the PMQR genes by themselves result in a low level of fluoroquinolone resistance. 4 To address the progression of antibiotic resistance in A. baumannii ATCC 17978, we attempted to isolate A. baumannii ATCC 17978 ciprofloxacin-resistant mutants by plating 10 8 -10 9 cfu on Mueller -Hinton agar plates containing 2×-16× the MIC of ciprofloxacin. Among the mutants analysed, we isolated a mutant named AB-7, which exhibited a ciprofloxacin MIC of 16 mg/L ( Table 1 ). The CLSI breakpoints for ciprofloxacin are ≤1 mg/L, susceptible; and ≥4 mg/L, resistant. 5 Additionally, the AB-7 strain also exhibited resistance to other fluoroquinolones tested, thus demonstrating class-wide resistance; however, AB-7 was not resistant to the unrelated antibiotic polymyxin B (Table 1) . Surprisingly, however, DNA sequencing of the QRDRs did not exhibit any mutations in gyrA, gyrB, parC and parE when compared with the parental strain ( Table 1) . A. baumannii ATCC 17978 has been whole-genome sequenced and the data have been deposited at the National Center for Biotechnology Information (NCBI; GenBank accession number CP000521.1).
6
The DNA sequence was then analysed for existence of the PMQR genes, namely qnr, qep and oqx. None of the PMQR genes was identified, as has been reported by multiple investigators. 3,7 -9 It has been speculated that a number of clinical bacterial isolates that express phenotypic resistance do not exhibit co-relatable genotypic mutations. This phenomenon has recently been reported in the HUE1 E. coli clinical isolate from Japan. 4 In comparison with the HUE1 E. coli isolate, no mutation was detected in the QRDRs as well as no PMQR genes in AB-7. However, other mechanisms may be involved in fluoroquinolone resistance and they are being investigated further. This finding demonstrates a clear exception to the well-accepted mechanism of resistance for fluoroquinolones. The results also underscore the importance of undertaking systems-level studies to re-learn mechanisms of action and evolution of resistance for conventional antibiotics.
In conclusion, we present the first report of fluoroquinolone resistance in A. baumannii that is independent of mutations in QRDRs and in the absence of PMQR.
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None to declare. Sir, Over the past decade, KPC-producing pathogens have spread in several large geographical regions, including Asia, Europe and South and North America. 1 In China, KPC-producing Klebsiella pneumoniae have emerged since 2007 in Shanghai and Zhejiang province, and recently have spread throughout the whole country. 2 The plasmid-mediated IMP-4 metallo-b-lactamase (MBL) was first detected in Citrobacter youngae from Guangzhou, China in 2001. 3 Yet, MBLs such as IMP-4 or IMP-8 are sporadically reported in Shanghai city and Hubei, Fujian, Zhejiang and Guangdong provinces. Recently, Klebsiella oxytoca co-producing IMP-8 and KPC-2 was reported in a children's hospital in Fujian province in China. 4 We report several broad-spectrum b-lactamases, including IMP-4 MBL, simultaneously located on different plasmids in KPC-producing isolates from China.
Four clinical isolates of K. pneumoniae (K1, K2, K3 and K4) were obtained from different patients (3 -12 months old) in a children's hospital in Wuhan city (Hubei province, China), from January 2008 to April 2009. During the four patients' hospitalization they had all been treated with multiple courses of antimicrobials, especially including imipenem or meropenem, carbenicillin, piperacillin/tazobactam, amoxicillin/clavulanic acid, cefepime and cefoperazone/sulbactam.
Antimicrobial susceptibility testing by Etest (bioMé rieux, France) showed that all four isolates were resistant to all b-lactam antibiotics according to CLSI 2011 (M100-S21) criteria, including carbapenems, with imipenem, meropenem and ertapenem MICs ranging from 3 to .32 mg/L. The isolates remained susceptible to ciprofloxacin (1 -2 mg/L), amikacin (2 -3 mg/L), tigecycline (0.38 -1 mg/L) and colistin (0.5 -1.5 mg/L).
PCR was performed for screening of the bla KPC , bla CTX-M , bla VEB , bla IMP , bla VIM , bla SHV and bla TEM genes, and six families of plasmid-mediated AmpC b-lactamase genes (MOX, CIT, DHA, ACC, EBC and FOX), as described previously.
2 PCR and sequencing identified bla KPC-2 and bla DHA-1 genes in all clinical isolates. In addition, K1, K2 and K4 harboured the bla CTX-M-15 gene, while K1, K3 and K4 harboured the bla IMP-4 gene.
Investigation of the bla KPC-2 genetic environment by PCR and sequencing revealed that the bla KPC-2 genetic context in K. pneumoniae isolates was identical to variant 1 of the genetic structure of bla KPC reported previously in China. 2 The genetic structure around the bla IMP-4 gene shared 99% identity with the class I integron of K. pneumoniae isolates reported in Shanghai (GenBank FJ384365), demonstrating the transmission of this structure in different areas of China.
PFGE demonstrated that all four K. pneumoniae isolates were clonally related (data not shown). A conjugation experiment showed that only an 80 kb bla CTX-M-15 -harbouring plasmid was transferable from K. pneumoniae isolates to a sodium azide-resistant Escherichia coli J53 recipient (K1, K2 and K4). S1-PFGE analysis revealed that the K1, K2 and K4 clinical isolates contained four plasmids, whereas K3 contained three plasmids, with sizes of 30 -300 kb (Figure 1 ). The hybridization results showed that the bla KPC-2 gene was located on plasmids of 30 kb in all four isolates. The bla IMP-4 gene was located on a plasmid of 300 kb in K1, K3 and K4. Strain K2 harboured a plasmid of just less than 300 kb and lacked the bla IMP-4 gene. The bla CTX-M-15 gene was located on a plasmid of 80 kb in K1, K2 and K4. The hybridization of bla DHA-1 showed two bands (80 and 300 kb). However, according to the negative results of the PCR amplification of the full-length bla DHA-1 gene in transconjugates carrying the 80 kb plasmid, we speculate that there is a truncated DHA-1 gene in this plasmid (Figure 1) .
According to the analysis of PCR-based plasmid replicon typing, 5 isolate K2 with a shortened plasmid has the accordant incompatibility groups with K1 and K4. It could be hypothesized that the 300 kb plasmid in K2 was shortened just because of a deletion of a segment containing the bla IMP-4 gene. In K3, the bla CTX-M-15 gene was not detected and the plasmid of 80 kb was lost. The plasmid incompatibility typing also showed that K3 lacks only an FIIs replicon compared with K1, K2 and K4.
